Clinical & Pharma

Climate Change Fuels a Public Health Emergency in Africa
Clinical & Pharma Climate Change Fuels a Public Health Emergency in Africa

The disproportionate burden of environmental transformation is nowhere more visible than across the African continent, where millions of lives are currently caught in the crosshairs of a climate-driven health crisis they did very little to create. While Africa is responsible for less than four

How Is Asia-Pacific Redefining Healthcare Regulation?
Clinical & Pharma How Is Asia-Pacific Redefining Healthcare Regulation?

The rapid acceleration of medical innovation across the Asia-Pacific region is forcing a fundamental rethink of how governing bodies balance patient safety with the urgent need for advanced technological solutions. Governments in nations like Australia, the Philippines, Japan, and India are

PMNCH Launches Campaign to Fund Women and Children’s Health
Clinical & Pharma PMNCH Launches Campaign to Fund Women and Children’s Health

A staggering decline in international development aid has created a precarious environment for global health, threatening to erase decades of progress achieved in maternal and pediatric care. The Partnership for Maternal, Newborn & Child Health recently introduced an essential two-year global

Who Is Accountable for Opioid Settlement Oversight?
Clinical & Pharma Who Is Accountable for Opioid Settlement Oversight?

Navigating the Multi-Billion Dollar Influx of Opioid Remediation Funds The distribution of fifty-eight billion dollars intended to combat the American addiction crisis marks a historic infusion of capital that could either redefine public health for the next decade or vanish into a labyrinth of

How Will the NIRBA Hub Shape the Future of RNA Science?
Clinical & Pharma How Will the NIRBA Hub Shape the Future of RNA Science?

The rapid evolution of molecular medicine has reached a transformative threshold with the official inauguration of the National Initiative for RNA Biology and its Applications Hub in Singapore. Spanning roughly 2,000 square meters at the National University of Singapore, this state-of-the-art

South Korean Drugmakers Race to Develop Oral Obesity Drugs
Clinical & Pharma South Korean Drugmakers Race to Develop Oral Obesity Drugs

The global pharmaceutical industry is witnessing a seismic shift as patients and healthcare providers pivot away from invasive injectable therapies in favor of more convenient oral weight-loss medications. This transition has triggered an intense technological rivalry among South Korean drugmakers

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later